FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to experimental studies in oncology and may be used for assessing the anti-tumour action of metal nanoparticles (NP). An iron nanoparticle suspension 1.25 mg/kg is introduced into grafted Pliss lymphosarcoma intratumourally. That is followed by the paratumoural introduction of methotrexate 0.2 mg/kg. The tumour is locally heated to temperature 42-43 DEG C using an electromagnetic UHF emission at frequency 12.7 MHz for 10 minutes. Th...

The present invention relates to a catalyst. The catalyst is used for converting acetic acid to ethanol. The catalyst comprises one or more active metals on an alkali metal silicate support or on an alkaline earth metal silicate support, wherein the support further comprises a silica enhancer and a support modifier.

The subject matter of the invention is a method for purifying carbon dioxide-containing process gases from the production of vinyl acetate after reacting ethylene with acetic acid and oxygen in heterogeneously catalysed continuous gas phase processes, characterised in that a carbon dioxide-containing process gas is guided through one or a plurality of CO2 absorbers that are equipped with filling material.

The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.

The present invention relates to a process for manufacturing a powder, comprising the following steps: . a) preparing a solution containing a solvent and zirconium oxalate, . b) adjusting the pH of the solution to a value above 5 and below 8, . c) introducing into the said solution a boehmite particle powder in an amount such that the ratio of the number of moles of zirconium element provided by the zirconium oxalate divided by the number of moles of aluminium element provided by the boehmite pa...

The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is stored for an extended period.

A catalyst is provided, the catalyst comprising rods having mean length of 100 microns or less, the rods comprising a metal molybdate or tungstate, the metal being selected from the group consisting of iron, manganese, nickel, chromium, vanadium, aluminium, silver, titanium, copper, bismuth, and cobalt. A method of making such a catalyst is also provided.

A catalyst for manufacturing a mixture of alcohols from synthesis gas comprises a combination of nickel, molybdenum, at least one metal selected from the group consisting of palladium, ruthenium, chromium, gold, zirconium, and aluminium, and at least one of an alkali metal or alkaline earth series metal as a promoter. The catalyst may be used in a process for converting synthesis gas wherein the primary product is a mixture of ethanol (EtOH), propanol (PrOH), and butanol (BuOH), optionally in co...

The invention relates to a hot-formable steel for use in hot forming comprising a hot- formable steel strip, sheet or blank, a metal or metal alloy coating formed on the hot- formable steel strip, sheet or blank and a metallurgical slag based coating formed on the metal or metal alloy coating, wherein the metal or metal alloy coating comprises zinc and/or aluminium and the metallurgical slag based coating comprises a metallurgical slag and a polymeric material.